1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Overview and Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Prevalence
4.5.1. By age group
4.5.2. By gender
4.5.3. By region
4.6. Product Pipeline
4.7. Innovations
5. ALCOHOL USE DISORDER TREATMENT MARKET BY TYPE
5.1. Alcohol Abuse
5.2. Alcoholism (Alcohol dependence)
6. ALCOHOL USE DISORDER TREATMENT MARKET BY TREATMENT
6.1. Medication
6.2. Behavioural Therapy
7. ALCOHOL USE DISORDER TREATMENT MARKET BY GEOGRAPHY
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. United Kingdom
7.3.4. Spain
7.3.5. Others
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.4.2. Israel
7.4.3. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. South Korea
7.5.4. India
7.5.5. Others
8. COMPETITIVE INTELLIGENCE
8.1. Competitive Benchmarking and Analysis
8.2. Recent Investments and Deals
8.3. Strategies of Key Players
9. COMPANY PROFILES
9.1. Teva Pharmaceuticals USA, Inc.
9.2. Adial Pharmaceuticals
9.3. Alkermes
9.4. ADDEX THERAPEUTICS
9.5. Kinnov Therapeutics
9.6. OPIANT PHARMACEUTICALS, INC
9.7. Ethypharm
9.8. MONTISERA LTD
LIST OF FIGURES
LIST OF TABLES